Home LiteratureArticle Details
PMID: 3643105 Published · ppublish English Journal Article

Vancomycin for treatment of infections with methicillin-resistant Staphylococcus aureus: are there alternatives?

European journal of clinical microbiology ·Vol. 5 ·No. 6 ·1986-12-00 ·Pages 689-92

Milatovic D

Abstract

暂无摘要

MeSH Terms
Anti-Bacterial Agents/therapeutic use Humans Methicillin/pharmacology Penicillin Resistance Staphylococcal Infections/drug therapy,microbiology Staphylococcus aureus/drug effects Vancomycin/therapeutic use
Chemicals
Anti-Bacterial Agents Vancomycin Methicillin
Authors & Affiliations
1 authors, click to expand affiliations / ORCID
Milatovic D
References (34)
34 references, click to expand
  1. Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain.
    J Infect Dis. 1981 Dec;144(6):575-82 PMID: 6977003
  2. Trimethoprim-sulfamethoxazole treatment of multiantibiotic-resistant staphylococcal endocarditis and meningitis.
    Clin Pediatr (Phila). 1982 Feb;21(2):125-6 PMID: 7056008
  3. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.
    Antimicrob Agents Chemother. 1984 Mar;25(3):319-26 PMID: 6232895
  4. Endocarditis due to methicillin-resistant Staphylococcus aureus in rabbits: expression of resistance to beta-lactam antibiotics in vivo and in vitro.
    J Infect Dis. 1984 Jun;149(6):894-903 PMID: 6564133
  5. In vitro activity of N-formimidoyl thienamycin and other beta-lactam antibiotics against methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 1982 Feb;21(2):341-3 PMID: 6951505
  6. Comparison of the activities of coumermycin, ciprofloxacin, teicoplanin, and other non-beta-lactam antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus from various geographical locations.
    Antimicrob Agents Chemother. 1985 Nov;28(5):634-8 PMID: 2936300
  7. Antibacterial activity of coumermycin alone and in combination with other antibiotics.
    Antimicrob Agents Chemother. 1984 Jun;25(6):687-9 PMID: 6331295
  8. Teicoplanin.
    J Antimicrob Chemother. 1984 Nov;14(5):441-5 PMID: 6239854
  9. Bacteremia due to methicillin-resistant Staphylococcus aureus.
    J Infect Dis. 1982 Apr;145(4):532-6 PMID: 6917874
  10. Emergence of rifampin-resistant strains of Staphylococcus aureus during combination therapy with vancomycin and rifampin: a report of two cases.
    Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S507-8 PMID: 6635441
  11. Interaction between vancomycin and rifampin against Staphylococcus aureus.
    Antimicrob Agents Chemother. 1981 Jun;19(6):1089-91 PMID: 7271276
  12. In-vitro effects of vancomycin and rifampicin, alone and in combination, against methicillin-sensitive and methicillin-resistant staphylococci.
    J Antimicrob Chemother. 1984 Dec;14 Suppl D:35-41 PMID: 6569872
  13. In-vitro activity of coumermycin against methicillin-resistant staphylococci: a comparison with six other agents.
    J Antimicrob Chemother. 1986 Aug;18(2):171-5 PMID: 3639086
  14. Vancomycin therapy of oxacillin-resistant Staphylococcus aureus infections.
    J Antimicrob Chemother. 1983 Apr;11(4):361-7 PMID: 6552258
  15. Antimicrobial chemotherapy of septicemia due to methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 1985 Dec;28(6):819-23 PMID: 3878691
  16. Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981.
    Antimicrob Agents Chemother. 1983 Jan;23(1):138-41 PMID: 6219616
  17. Short-term administration of rifampin in the prevention or eradication of infection due to foreign bodies.
    Rev Infect Dis. 1983 Jul-Aug;5 Suppl 3:S474-80 PMID: 6356279
  18. In vitro susceptibility of methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains to N-formimidoyl thienamycin.
    Antimicrob Agents Chemother. 1982 Nov;22(5):906-8 PMID: 6960806
  19. Epidemic of hospital-acquired infection due to methicillin-resistant Staphylococcus aureus in major Victorian hospitals.
    Med J Aust. 1982 May 29;1(11):451-4 PMID: 7099074
  20. The emergence of methicillin-resistant Staphylococcus aureus infections in United States hospitals. Possible role of the house staff-patient transfer circuit.
    Ann Intern Med. 1982 Sep;97(3):297-308 PMID: 7114626
  21. In-vitro effects of vancomycin, rifampicin, and fusidic acid, alone and in combination, against methicillin-resistant Staphylococcus aureus.
    J Antimicrob Chemother. 1983 Jan;11(1):21-6 PMID: 6826485
  22. Activity of eleven antimicrobial agents against methicillin-, methicillin- and rifampin-resistant Staphylococcus aureus.
    Chemotherapy. 1984;30(2):97-101 PMID: 6559665
  23. Evolution and epidemiology of MLS resistance.
    J Antimicrob Chemother. 1985 Jul;16 Suppl A:137-49 PMID: 3932300
  24. Antistaphylococcal activity of rifampin with other antibiotics.
    J Infect Dis. 1981 Oct;144(4):365-71 PMID: 6270215
  25. In vitro susceptibility patterns of methicillin-resistant and-susceptible Staphylococcus auerues strains in a population of parenteral drug abusers from 1972 to 1981.
    Antimicrob Agents Chemother. 1983 Mar;23(3):450-7 PMID: 6552151
  26. Growing clinical significance of methcillin-resistant Staphylococcus aureus.
    Lancet. 1968 Oct 5;2(7571):741-4 PMID: 4175546
  27. Vancomycin therapy for methicillin-resistant Staphylococcus aureus.
    Ann Intern Med. 1982 Sep;97(3):344-50 PMID: 7114631
  28. Methicillin-resistant staphylococcemia: bacteriological failure of treatment with cephalosporins.
    Antimicrob Agents Chemother (Bethesda). 1970;10:280-5 PMID: 4939735
  29. Disparity between timed-kill and checkerboard methods for determination of in vitro bactericidal interactions of vancomycin plus rifampin versus methicillin-susceptible and -resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 1984 Aug;26(2):220-3 PMID: 6567464
  30. Interaction of intraleukocytic bacteria and antibiotics.
    J Clin Invest. 1973 Jul;52(7):1673-9 PMID: 4718959
  31. Guidelines for the control of epidemic methicillin-resistant Staphylococcus aureus. Report of a combined working party of the Hospital Infection Society and British Society for Antimicrobial Chemotherapy.
    J Hosp Infect. 1986 Mar;7(2):193-201 PMID: 2871084
  32. Nephrotoxicity associated with vancomycin-aminoglycoside therapy in four children.
    J Pediatr. 1984 Sep;105(3):491-3 PMID: 6470874
  33. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    J Infect Dis. 1985 Jan;151(1):157-65 PMID: 3965588
  34. Teicoplanin versus nafcillin and vancomycin in the treatment of experimental endocarditis caused by methicillin-susceptible or -resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 1984 Jul;26(1):61-4 PMID: 6236747
Article Info
Journal
European journal of clinical microbiology
Abbr.
Eur J Clin Microbiol
ISSN
0722-2211
DOI
10.1007/BF02013306
Published
1986-12-00
Pages
689-92
Language
English
Region
Germany
NLM ID
8219582
Subset
IM
External Links
PubMed source DOI: 10.1007/BF02013306
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2